Previous close | 15.81 |
Open | 14.24 |
Bid | 14.22 x 30000 |
Ask | 14.35 x 30000 |
Day's range | 14.24 - 14.24 |
52-week range | 14.24 - 29.40 |
Volume | |
Avg. volume | 8 |
Market cap | 2.354B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | ∞ |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It's been a mediocre week for ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) shareholders, with the stock dropping 11% to...
ACADIA's Revenue Surges with Strong Sales from NUPLAZID and DAYBUE
ACADIA Pharmaceuticals ( NASDAQ:ACAD ) First Quarter 2024 Results Key Financial Results Revenue: US$205.8m (up 74% from...